Glucose induced IEG expression in the thiamin-deficient rat brain

Brain Research

Volumn 892, Issue 1, 2001, Pages 218-227

  Zimitat, Craig ^a   Nixon, Peter F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brain damage; IEG expression; Thiamin deficiency; Wernicke's encephalography

Indexed keywords

GLUCOSE; PROTEIN FOS; THIAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN TISSUE; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE METABOLISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROPATHY; NONHUMAN; OPISTHOTONUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THIAMINE DEFICIENCY; TISSUE DISTRIBUTION; WERNICKE ENCEPHALOPATHY;

ANIMALS; ANTIMETABOLITES; BRAIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, FOS; GENES, IMMEDIATE-EARLY; GLUCOSE; HUMANS; ORGAN SPECIFICITY; PYRITHIAMINE; RATS; RATS, WISTAR; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

EID: 0035895833     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03297-2     Document Type: Article

References (47)

1. Low energy levels in thiamin deficiency encephalopathy
2. The effect of thiamin deficiency on the structure and physiology of the rat forebrain
3. Pitfalls in assessment of c-fos mRNA expression in the brain: Effects of animal handling
4. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex
5. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 2. α-ketoglutarate complex
6. Blood brain barrier abnormalities in vulnerable brain regions during thiamin deficiency
7. Cerebellar degeneration in thiamin deficiency rats
8. Some regional pathologic and metabolic consequences in mouse brain of pyrithiamin induced thiamin deficiency
9. The regulation of c-fos: Too much is never enough
10. FOS and JUN as markers for ethanol sensitive pathways in the rat brain
11. The use of c-fos as a metabolic marker in neuronal pathway tracing
12. Effects of thiamin deficiency of the central nervous system
13. Analysis of Fos protein complexes and Fos-related antigens by high resolution two-dimensional gel electrophoresis
14. The Fos complex and Fos-related antigen recognise sequence elements that contain AP-1 sites
15. Correlation of enzymatic, metabolic and behavioural deficits in thiamin deficiency and its reversal
16. Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy: 3. Transketolase
17. The induction and reversabililty of cerebral acidosis in thiamin deficiency
18. Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency
19. Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency
20. Immediate early gene expression in the brain of the thiamine-deficient rat
21. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system
22. Excitotoxicity and neurodegenerative diseases
23. Changes in the hippocampus induced by glucose in TD rats detected by MRI
24. Swelling induced release of glutamate, aspartate and taurine from astrocyte cultures
25. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain
26. Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801
27. Stimulus transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
28. Mapping patterns of c-fos expression in the central nervous system after seizure
29. Proto-oncogene c-fos induction in thiamine-deficient encephalopathy
30. A study of the nutritional defect in Wernicke's syndrome
31. Ultrastructural features of early brainstem lesions of thiamin deficiency rats
32. MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in rats
33. 1H MRS to study biochemical changes in the thiamin deficiency rat brain under glucose load
34. Localisation of neuronal and glial glutamate transporters
35. Expression of c-fos protein in brain: Metabolic mapping at the cellular level
36. Continuous c-fos expression precedes programmed cell death in vivo
37. In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression
38. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke's encephalopathy
39. Model of Wernicke's encephalopathy
40. Coma in the Wernicke-Korsakof syndrome
41. Acute Wernikce's encephalopathy precipitated by glucose loading
42. In situ hybridisation analysis of c-fos and c-jun expression in the rat brain following transient forebrain ischaemia
43. MRI demonstration of impairment of the blood-CSF barrier by glucose administration to the thiamin deficiency rat brain
44. Excitotoxic cytopathology, progression, and reversibility of thiamin-deficiency induced diencephalic lesions
45. Glucose loading precipitates acute encephalopathy in thiamin deficiency rats
46. Progression of neurological disease in thiamin deficiency rats is enhanced by ethanol